(Q37419058)

20 August 2017

1 reference

title

alpha4-Integrin antagonism with natalizumab: effects and adverse effects (English)

1 reference

20 August 2017

1

Olaf Stüve

1 reference

20 August 2017

6

Bernd C Kieseier

1 reference

20 August 2017

2

Ralf Gold

1 reference

20 August 2017

Andrew Chan

3

1 reference

20 August 2017

Eilhard Mix

series ordinal

4

1 reference

20 August 2017

Uwe Zettl

series ordinal

5

1 reference

20 August 2017

publication date

1 December 2008

1 reference

20 August 2017

1 reference

20 August 2017

volume

255 Suppl 6

1 reference

20 August 2017

page(s)

58-65

1 reference

Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-008-6011-0

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

12 December 2020

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

12 December 2020

Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease.

1 reference

12 December 2020

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

12 December 2020

Engineering antibodies for therapy

1 reference

12 December 2020

Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

1 reference

12 December 2020

Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines

1 reference

12 December 2020

Integrin cytoplasmic domain-binding proteins

1 reference

12 December 2020

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients

1 reference

12 December 2020

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

12 December 2020

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

12 December 2020

E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

12 December 2020

Immunohistochemical characterization of the mononuclear cells in the brain of the rat with an experimental chronic Trypanosoma brucei gambiense infection

1 reference

12 December 2020

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

1 reference

12 December 2020

Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

1 reference

12 December 2020

Immunological aspects of demyelinating diseases

1 reference

12 December 2020

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions

1 reference

12 December 2020

The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2.

1 reference

12 December 2020

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

12 December 2020

A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

1 reference

12 December 2020

Integrin avidity regulation: are changes in affinity and conformation underemphasized?

1 reference

12 December 2020

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

12 December 2020

Spontaneous remyelination following prolonged inhibition of alpha4 integrin in chronic EAE

1 reference

12 December 2020

Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis

1 reference

12 December 2020

β7 integrins contribute to demyelinating disease of the central nervous system

1 reference

12 December 2020

Immune cell migration in inflammation: present and future therapeutic targets

1 reference

12 December 2020

Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.

1 reference

12 December 2020

Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Immune surveillance in multiple sclerosis patients treated with natalizumab.

1 reference

12 December 2020

Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin

1 reference

12 December 2020

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

1 reference

12 December 2020

Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of alpha4 integrin.

1 reference

12 December 2020

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

12 December 2020

A controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

12 December 2020

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

1 reference

12 December 2020

Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

1 reference

12 December 2020

10.1007/S00415-008-6011-0

Identifiers

DOI

1 reference

20 August 2017

1 reference